Tharimmune Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:THAR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
15 Dec 23	BuyUS$14,587	Randy Milby	Individual		1,933.33	US$7.54
30 Nov 23	BuyUS$10,000	Randy Milby	Individual		666.67	US$15.00

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1653.1%.

Top 15 shareholders own 2.37% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.33%	Randy Milby	10,434	US$34.6k	0%	no data
0.43%	Sireesh Appajosyula	3,350	US$11.1k	0%	no data
0.15%	XTX Holdings Limited, Asset Management Arm	1,162	US$3.9k	0%	no data
0.12%	Renaissance Technologies LLC	913	US$3.0k	0%	no data
0.11%	Two Sigma Advisers, LP	846	US$2.8k	0%	no data
0.088%	Two Sigma Investments, LP	694	US$2.3k	0%	no data
0.085%	Warberg Asset Management LLC	666	US$2.2k	0%	0.01%
0.042%	Leonard Mazur	330	US$1.1k	0%	no data
0.013%	Tower Research Capital LLC	100	US$331.9	11.1%	no data
0.013%	Geode Capital Management, LLC	100	US$331.9	2.04%	no data
0.0037%	The Vanguard Group, Inc.	29	US$96.3	3.57%	no data
0.0025%	Channel Bioconsulting, Llc	20	US$66.3	0%	no data
0.00076%	Blackstone Alternative Investment Advisors LLC	6	US$19.8	0%	no data
0.00013%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$3.4	0%	no data
0.00013%	Wells Fargo & Company, Private Banking and Investment Banking Arm	1	US$3.4	0%	no data